Rel Life Sciences lines up Rs 2,500 crore investment – Times of India
MUMBAI: Mukesh Ambani-owned Reliance Life Sciences has earmarked Rs 2,500 crore over the next two years for developing innovative gene...
MUMBAI: Mukesh Ambani-owned Reliance Life Sciences has earmarked Rs 2,500 crore over the next two years for developing innovative gene...
Starting July 1, all non-banking institutions would not be allowed to load credit lines to prepaid payment instruments (PPI) such...
NEW DELHI: India's scheme to break Amazon and Walmart's dominance of its e-commerce sector, by establishing its own open network,...